We read with interest the recent paper by Hsieh and colleagues [1] asserting that cytomegalovirus (CMV) induces systemic lupus erythematosus (SLE) in genetically susceptible individuals. Th is assertion is based on the idea that SLE-associated autoantibodies that had been induced by a certain fragment of CMV were found in rodents. However, our previous studies have reported that autoantibodies detected in SLE and viral infection are diff erent, especially with regard to the anti-microtubule organizing center with microtubule (anti-MTOC-MT) [2][3][4]. We conducted a retrospective study comparing autoantibodies in three groups: anti-CMV IgMpositive SLE patients (SLE-CMV group); anti-CMV IgMpositive patients without SLE (CMV group); and anti-CMV IgM-negative SLE patients (SLE group). Th is study was approved by the institutional review board of Hanyang University Medical Center.
anti-CMV IgG does not protect the individual from reactiva tion of the latent virus. In contrast, anti-CMV IgM responses are often seen during reactivation of CMV, so it seems that CMV infection in the SLE-CMV group was not caused by primary infection but by reactivation of CMV. MTOC, cytokines and T cells are closely co ordinated to maintain the immune system [5] and anti-MTOC-MT is not found in SLE patients owing to impairment of the immune system. In conclusion, we postulate that CMV is not suffi ciently intense to cause SLE, but is reactivated in some SLE patients as an innocent bystander. In the CMV group, anti-MTOC-MT-positive patients accounted for 72.7% of the total patients in the CMV group and 88.9% of autoantibody-positive patients, but in the SLE-CMV group, anti-MTOC-MT was not detected at all (P < 0.001). Patients in the SLE-CMV group showed high titers of over 1:640 except for one who received steroid pulse therapy just before the test, but the proportion of patients in the CMV group with a titer over 1:640 was not more than 13.6% (P < 0.001). In addition, most of the autoantibody frequently found in the SLE-CMV group was not found in the CMV group. AIT, autoimmune target; CMV, cytomegalovirus; IF, intermediate fi lament; MTOC-MT, microtubule organizing center with microtubule; SLE, systemic lupus erythematosus.
